宫颈癌术后盆腔放疗中移位卵巢位置与卵巢剂量的关联
该回顾性研究分析了150例接受根治性子宫切除术、术中卵巢移位及术后辅助盆腔放疗的年轻宫颈癌患者,探讨移位卵巢位置与卵巢剂量的关联。ROC分析显示,卵巢高于髂嵴平面>1.12 cm与卵巢位于PTV上界以上显著相关;卵巢位于PTV上界以下时,卵巢与PTV横向距离>3.265 cm与卵巢Dmax≤4Gy显著相关,>2.391 cm与Dmax≤5Gy显著相关。77例完成随访的患者中,放疗后1年卵巢功能保留率为72.7%,显著高于3个月时的44.2%。
要点
- 卵巢高于髂嵴平面>1.12 cm与卵巢位于PTV上界以上显著相关。
- 卵巢位于PTV上界以下时,横向距离>3.265 cm与Dmax≤4Gy相关。
- 横向距离>2.391 cm与卵巢Dmax≤5Gy相关。
核心结论
- 宫颈癌患者移位卵巢的位置与辅助放疗中卵巢剂量显著相关。
- 建议将卵巢移位至高于髂嵴平面>1.12 cm以获得卵巢位于PTV以上的位置。
- 当移位卵巢位于PTV上界以下时,卵巢与PTV横向距离>3.265 cm可获得卵巢Dmax≤4Gy,>2.391 cm可获得Dmax≤5Gy。
研究设计与样本
- 回顾性分析150例在浙江省肿瘤医院接受根治性子宫切除术、术中卵巢移位及术后辅助放疗的年轻宫颈癌患者。
- 评估移位卵巢位置与卵巢剂量的关联,并使用ROC曲线分析探索满意剂量下的移位位置。
- 放疗后3个月和1年随访卵巢功能。
主要发现
- 32/214(15%)移位卵巢高于PTV上界。
- 卵巢高于髂嵴平面>1.12 cm与卵巢位于PTV上界以上显著相关。
- 卵巢位于PTV上界以下时,横向距离>3.265 cm与卵巢Dmax≤4Gy显著相关,>2.391 cm与Dmax≤5Gy显著相关。
- 77例完成随访,56例(72.7%)放疗后1年卵巢功能保留,显著高于3个月时的44.2%。
关键数值与推荐
- 卵巢高于髂嵴平面>1.12 cm:与卵巢位于PTV上界以上显著相关。
- 卵巢位于PTV上界以下时,卵巢与PTV横向距离>3.265 cm:与卵巢Dmax≤4Gy显著相关。
- 卵巢位于PTV上界以下时,卵巢与PTV横向距离>2.391 cm:与卵巢Dmax≤5Gy显著相关。
临床怎么用
- 宫颈癌术后需盆腔放疗的患者,术中可参考将卵巢移位至高于髂嵴平面>1.12 cm以使其位于PTV以上。
- 若移位卵巢位于PTV上界以下,可参考横向距离>3.265 cm或>2.391 cm分别对应Dmax≤4Gy或≤5Gy的关联。
局限性
- 本研究为单中心回顾性分析。
- 仅77例患者完成完整随访,卵巢功能随访数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: How to protect the ovarian function during radiotherapy is uncertain. The purpose of this study was to explore the association between the location of the transposed ovary and the ovarian dose in patients with cervical cancer received radical hysterectomy, ovarian transposition, and postoperative pelvic radiotherapy. METHODS: A retrospective analysis was conducted of 150 young patients with cervical cancer who received radical hysterectomy, intraoperative ovarian transposition, and postoperative adjuvant radiotherapy in Zhejiang Cancer Hospital. Association between location of the transposed ovaries and ovarian dose was evaluated. The transposed position of ovaries with a satisfactory dose was explored using a receiver operator characteristic curve (ROC) analysis. Patients' ovarian function was followed up 3 months and 1 year after radiotherapy. RESULTS: A total of 32/214 (15%) transposed ovaries were higher than the upper boundary of the planning target volume (PTV). The optimum cutoff value of > 1.12 cm above the iliac crest plane was significantly associated with ovaries above the upper PTV boundary. When the ovaries were below the upper boundary of PTV, the optimum cutoff value of transverse distance > 3.265 cm between the ovary and PTV was significantly associated with ovarian max dose (Dmax) ≤ 4Gy, and the optimum cutoff value of transverse distance > 2.391 cm was significantly associated with ovarian Dmax≤5Gy. A total of 77 patients had received complete follow-up, and 56 patients (72.7%) showed preserved ovarian function 1 year after radiotherapy, which was significantly increased compared with 3 months (44.2%) after radiotherapy. CONCLUSIONS: The location of transposed ovaries in patients with cervical cancer is significantly correlated with ovarian dose in adjuvant radiotherapy. We recommend transposition of ovaries > 1.12 cm higher than the iliac crest plane to obtain ovarian location above PTV. When the transposed ovary is below the upper boundary of PTV, ovarian Dmax ≤4Gy may be obtained when the transverse distance between the ovary and PTV was > 3.265 cm, and the ovarian Dmax≤5Gy may be obtained when the transverse distance was > 2.391 cm.
引用
- Lv XJ, Cheng XL, Tu YQ, et al. Association between the location of transposed ovary and ovarian dose in patients with cervical cancer treated with postoperative pelvic radiotherapy. Radiat Oncol. 2019. PMID: 31842971. doi:10.1186/s13014-019-1437-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。